These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10751135)

  • 1. A simplified pharmacologic erection program for patients with spinal cord injury.
    Zaslau S; Nicolis C; Galea G; Britanico J; Vapnek JM
    J Spinal Cord Med; 1999; 22(4):303-7. PubMed ID: 10751135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient satisfaction with pharmacologic erection program.
    Hollander JB; Gonzalez J; Norman T
    Urology; 1992 May; 39(5):439-41. PubMed ID: 1580034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.
    Polito M; d'Anzeo G; Conti A; Muzzonigro G
    BJU Int; 2012 Dec; 110(11 Pt C):E954-7. PubMed ID: 23078100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
    Chochina L; Naudet F; Chéhensse C; Manunta A; Damphousse M; Bonan I; Giuliano F
    Sex Med Rev; 2016 Jul; 4(3):257-269. PubMed ID: 27871959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernous injections of prostaglandin E1 for erectile dysfunction: patient satisfaction and quality of sex life on long-term treatment.
    Alexandre B; Lemaire A; Desvaux P; Amar E
    J Sex Med; 2007 Mar; 4(2):426-31. PubMed ID: 17367438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction.
    Kunelius P; Lukkarinen O
    Int J Impot Res; 1999 Feb; 11(1):21-4. PubMed ID: 10098949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients].
    Lebib Ben Achour S; Laffont I; Boyer F; Boiteau F; Dizien O
    Ann Readapt Med Phys; 2001 Feb; 44(1):35-40. PubMed ID: 11587653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernous self-injection therapy for the treatment of erectile dysfunction.
    Chiang HS; Wen TC; Wu CC; Chiang WH
    J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
    Engel JD; McVary KT
    Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction.
    Soderdahl DW; Thrasher JB; Hansberry KL
    Br J Urol; 1997 Jun; 79(6):952-7. PubMed ID: 9202565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of a second injection on the pharmaco-induced erection test.
    Pagani E; Puech-Leão P; Glina S; Reis JM
    Int J Impot Res; 1997 Sep; 9(3):167-8. PubMed ID: 9315495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers.
    Watanabe T; Chancellor MB; Rivas DA; Hirsch IH; Bennett CJ; Finocchiaro MV; Razi S; Bennett JK; Green BG; Foote JE; Killorian RW; Juma S; Linsenmeyer TA; Lloyd K
    J Spinal Cord Med; 1996 Jul; 19(3):186-9. PubMed ID: 8819027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury.
    Bodner DR; Haas CA; Krueger B; Seftel AD
    Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery.
    Nelson CJ; Hsiao W; Balk E; Narus J; Tal R; Bennett NE; Mulhall JP
    J Sex Med; 2013 Oct; 10(10):2559-65. PubMed ID: 23898886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
    Purvis K; Egdetveit I; Christiansen E
    Int J Impot Res; 1999 Oct; 11(5):287-99. PubMed ID: 10553808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
    Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI
    J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved vasoactive drug combination for a pharmacological erection program.
    Bennett AH; Carpenter AJ; Barada JH
    J Urol; 1991 Dec; 146(6):1564-5. PubMed ID: 1719248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.